Welcome to LookChem.com Sign In|Join Free
  • or
4-Bromo-3-nitrobenzonitrile is a chemical compound characterized by the molecular formula C7H3BrN2O2. It is a yellow crystalline solid known for its versatile reactivity, making it a valuable intermediate in the synthesis of pharmaceuticals, dyes, and agricultural chemicals. Due to its potential health hazards, it is essential to handle and store 4-Bromo-3-nitrobenzonitrile under controlled conditions and with caution in laboratory or industrial settings.

89642-49-9

Post Buying Request

89642-49-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

89642-49-9 Usage

Uses

Used in Pharmaceutical Industry:
4-Bromo-3-nitrobenzonitrile is used as a key intermediate in the synthesis of various pharmaceutical compounds. Its unique structure and reactivity allow for the development of new drugs with improved therapeutic properties.
Used in Dye Industry:
In the dye industry, 4-Bromo-3-nitrobenzonitrile serves as an essential building block for the production of a wide range of dyes. Its incorporation into dye molecules contributes to the creation of dyes with enhanced color properties and stability.
Used in Agricultural Chemicals Industry:
4-Bromo-3-nitrobenzonitrile is utilized as a crucial intermediate in the synthesis of agricultural chemicals, such as pesticides and herbicides. Its presence in these compounds aids in enhancing their effectiveness and selectivity in controlling pests and weeds.
Used in Chemical Research:
4-Bromo-3-nitrobenzonitrile plays a significant role in chemical research, where it is employed as a versatile reagent for various organic reactions. Its unique properties enable the exploration of new reaction pathways and the development of innovative synthetic methods.
Used in Manufacturing Processes:
In manufacturing processes, 4-Bromo-3-nitrobenzonitrile is used as a vital component in the production of various organic compounds. Its presence in these processes ensures the synthesis of high-quality products with desired properties and performance characteristics.

Check Digit Verification of cas no

The CAS Registry Mumber 89642-49-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,9,6,4 and 2 respectively; the second part has 2 digits, 4 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 89642-49:
(7*8)+(6*9)+(5*6)+(4*4)+(3*2)+(2*4)+(1*9)=179
179 % 10 = 9
So 89642-49-9 is a valid CAS Registry Number.
InChI:InChI=1/C7H3BrN2O2/c8-6-2-1-5(4-9)3-7(6)10(11)12/h1-3H

89642-49-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-Bromo-3-nitrobenzonitrile

1.2 Other means of identification

Product number -
Other names 4-BROMO-3-NITROBENZONITRILE

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:89642-49-9 SDS

89642-49-9Relevant academic research and scientific papers

Compositions for Treatment of Cystic Fibrosis and Other Chronic Diseases

-

Paragraph 0673, (2015/09/22)

The present invention relates to pharmaceutical compositions comprising an inhibitor of epithelial sodium channel activity in combination with at least one ABC Transporter modulator compound of Formula A, Formula B, Formula C, or Formula D. The invention also relates to pharmaceutical formulations thereof, and to methods of using such compositions in the treatment of CFTR mediated diseases, particularly cystic fibrosis using the pharmaceutical combination compositions.

COMPOSITIONS FOR TREATMENT OF CYSTIC FIBROSIS AND OTHER CHRONIC DISEASES

-

, (2012/04/23)

The present invention relates to pharmaceutical compositions comprising an inhibitor of epithelial sodium channel activity in combination with at least one ABC Transporter modulator compound of Formula A, Formula B, Formula C, or Formula D. The invention also relates to pharmaceutical formulations thereof, and to methods of using such compositions in the treatment of CFTR mediated diseases, particularly cystic fibrosis using the pharmaceutical combination compositions.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 89642-49-9